Income Strikes Back: 3 Must-Own Dividend Stocks For What's Coming — Positive

NEE  NTST  PEP   Seeking Alpha — May 22, 2025

I believe stocks are superior to bonds long term, especially during inflationary periods. But recent trends suggest bonds are becoming more competitive. Higher bond yields and rising stock valuations have made the risk/reward balance less favorable for stocks, especially defensive, income-oriented ones. I'm not buying bonds, but I see big opportunities in high-quality dividend stocks that have fallen out of favor, but still offer strong long-term growth.

image for news Income Strikes Back: 3 Must-Own Dividend Stocks For What's Coming

scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025 — Neutral

SCPH   Seeking Alpha — May 22, 2025

Shares of scPharmaceuticals have lost 37% over the past 3 years and are down 11% in 2025. Furoscix's subcutaneous administration offers the potential to keep heart failure patients at home longer and cut down on hospital readmissions. Q1 seasonality is in the rearview mirror, with multiple tailwinds, including Medicare redesign and label expansion, to fuel growth going forward.

image for news scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025

BJ's Wholesale Club Results Strengthen, Backs FY25 Outlook — Positive

BJ   WSJ — May 22, 2025

The Marlborough, Mass., warehouse club said it recorded net income of $149.8 million, or $1.13 a share, for the first quarter ended May 3, up from $111 million, or 83 cents a share, in the prior-year period.

image for news BJ's Wholesale Club Results Strengthen, Backs FY25 Outlook

NVIDIA's Q1 Earnings Coming Up: Time to Buy, Sell or Hold the Stock? — Neutral

NVDA   Zacks Investment Research — May 22, 2025

Strong demand for generative AI and LLM-supportive GPUs from data center operators is likely to have aided NVDA's Q1 performance.

image for news NVIDIA's Q1 Earnings Coming Up: Time to Buy, Sell or Hold the Stock?

Viking Therapeutics: Weight-Loss Story Remains Intact — Positive

VKTX   Seeking Alpha — May 22, 2025

Viking Therapeutics remains a promising weight-loss drug biotech due to the enrollment of new promising trials. The weight-loss sector's momentum has faded some, but Eli Lilly and Novo Nordisk have still generated substantial value for shareholders. Viking Therapeutics has upcoming catalysts, including late-July Phase 2 oral data and Phase 3 injectable trial enrollment, potentially driving significant upside in the stock.

image for news Viking Therapeutics: Weight-Loss Story Remains Intact

Bitcoin was trading in uncharted territory and hovering around $110,000 Thursday morning.

image for news Coinbase, Robinhood, Other Crypto Stocks Rise. Thank Bitcoin Hitting New Highs.

Should You Invest in the First Trust Water ETF (FIW)? — Neutral

FIW   Zacks Investment Research — May 22, 2025

If you're interested in broad exposure to the Industrials - Water segment of the equity market, look no further than the First Trust Water ETF (FIW), a passively managed exchange traded fund launched on 05/08/2007.

image for news Should You Invest in the First Trust Water ETF (FIW)?

Is WisdomTree International Equity ETF (DWM) a Strong ETF Right Now? — Neutral

DWM   Zacks Investment Research — May 22, 2025

A smart beta exchange traded fund, the WisdomTree International Equity ETF (DWM) debuted on 06/16/2006, and offers broad exposure to the Broad Developed World ETFs category of the market.

image for news Is WisdomTree International Equity ETF (DWM) a Strong ETF Right Now?

Is Schwab Fundamental U.S. Large Company ETF (FNDX) a Strong ETF Right Now? — Neutral

FNDX   Zacks Investment Research — May 22, 2025

The Schwab Fundamental U.S. Large Company ETF (FNDX) was launched on 08/13/2013, and is a smart beta exchange traded fund designed to offer broad exposure to the Style Box - Large Cap Value category of the market.

image for news Is Schwab Fundamental U.S. Large Company ETF (FNDX) a Strong ETF Right Now?

Should You Invest in the Invesco Global Water ETF (PIO)? — Neutral

PIO   Zacks Investment Research — May 22, 2025

Designed to provide broad exposure to the Industrials - Water segment of the equity market, the Invesco Global Water ETF (PIO) is a passively managed exchange traded fund launched on 06/13/2007.

image for news Should You Invest in the Invesco Global Water ETF (PIO)?

Looking for broad exposure to the Large Cap Value segment of the US equity market? You should consider the Invesco S&P 500 High Dividend Low Volatility ETF (SPHD), a passively managed exchange traded fund launched on 10/18/2012.

image for news Should Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) Be on Your Investing Radar?

Should You Invest in the Invesco S&P 500 Equal Weight Financials ETF (RSPF)? — Neutral

RSPF   Zacks Investment Research — May 22, 2025

Looking for broad exposure to the Financials - Broad segment of the equity market? You should consider the Invesco S&P 500 Equal Weight Financials ETF (RSPF), a passively managed exchange traded fund launched on 11/01/2006.

image for news Should You Invest in the Invesco S&P 500 Equal Weight Financials ETF (RSPF)?

Should Invesco S&P 100 Equal Weight ETF (EQWL) Be on Your Investing Radar? — Neutral

EQWL   Zacks Investment Research — May 22, 2025

If you're interested in broad exposure to the Large Cap Blend segment of the US equity market, look no further than the Invesco S&P 100 Equal Weight ETF (EQWL), a passively managed exchange traded fund launched on 12/01/2006.

image for news Should Invesco S&P 100 Equal Weight ETF (EQWL) Be on Your Investing Radar?

Should SPDR Portfolio S&P 400 Mid Cap ETF (SPMD) Be on Your Investing Radar? — Neutral

SPMD   Zacks Investment Research — May 22, 2025

Looking for broad exposure to the Mid Cap Blend segment of the US equity market? You should consider the SPDR Portfolio S&P 400 Mid Cap ETF (SPMD), a passively managed exchange traded fund launched on 11/08/2005.

image for news Should SPDR Portfolio S&P 400 Mid Cap ETF (SPMD) Be on Your Investing Radar?

Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)? — Neutral

RSPH   Zacks Investment Research — May 22, 2025

Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the Invesco S&P 500 Equal Weight Health Care ETF (RSPH), a passively managed exchange traded fund launched on 11/01/2006.

image for news Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?

Should SPDR Portfolio S&P 500 Growth ETF (SPYG) Be on Your Investing Radar? — Neutral

SPYG   Zacks Investment Research — May 22, 2025

Looking for broad exposure to the Large Cap Growth segment of the US equity market? You should consider the SPDR Portfolio S&P 500 Growth ETF (SPYG), a passively managed exchange traded fund launched on 09/25/2000.

image for news Should SPDR Portfolio S&P 500 Growth ETF (SPYG) Be on Your Investing Radar?

Is Invesco S&P 500 Equal Weight Energy ETF (RSPG) a Strong ETF Right Now? — Neutral

RSPG   Zacks Investment Research — May 22, 2025

The Invesco S&P 500 Equal Weight Energy ETF (RSPG) was launched on 11/01/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Energy ETFs category of the market.

image for news Is Invesco S&P 500 Equal Weight Energy ETF (RSPG) a Strong ETF Right Now?

Should You Invest in the Fidelity MSCI Energy Index ETF (FENY)? — Neutral

FENY   Zacks Investment Research — May 22, 2025

Looking for broad exposure to the Energy - Broad segment of the equity market? You should consider the Fidelity MSCI Energy Index ETF (FENY), a passively managed exchange traded fund launched on 10/21/2013.

image for news Should You Invest in the Fidelity MSCI Energy Index ETF (FENY)?

Is VanEck Morningstar Wide Moat ETF (MOAT) a Strong ETF Right Now? — Neutral

MOAT   Zacks Investment Research — May 22, 2025

The VanEck Morningstar Wide Moat ETF (MOAT) was launched on 04/24/2012, and is a smart beta exchange traded fund designed to offer broad exposure to the Style Box - Large Cap Blend category of the market.

image for news Is VanEck Morningstar Wide Moat ETF (MOAT) a Strong ETF Right Now?

Should Vanguard Growth ETF (VUG) Be on Your Investing Radar? — Neutral

VUG   Zacks Investment Research — May 22, 2025

Designed to provide broad exposure to the Large Cap Growth segment of the US equity market, the Vanguard Growth ETF (VUG) is a passively managed exchange traded fund launched on 01/26/2004.

image for news Should Vanguard Growth ETF (VUG) Be on Your Investing Radar?